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NAS and ADHD
Abstract
Background: Neonatal abstinence syndrome (NAS) is the set of signs and symptoms present in a
newborn whose mother was addicted to drugs while pregnant. NAS can occur due to sudden withdrawal
from several drugs, including opioids, benzodiazepines, methamphetamines, and caffeine. It can cause
many different issues in the newborn, including diarrhea, tremors, fever, and seizures. While these
specific signs and symptoms are self-limited, research is showing that these children grow in to
childhood and adolescence with increased risk of Attention-Deficit/Hyperactivity Disorder (ADHD),
autism, motor dysregulation, and other cognitive and behavioral sequelae.
Purpose: The purpose of this project was to establish a correlation between a diagnosis of NAS in
infancy and a diagnosis of ADHD later in adolescence. This was a retrospective chart review of a large
academic health science center’s electronic health record system that identified children who had a
diagnosis of NAS in infancy and then later received a diagnosis of ADHD. The goal of this chart review
was to identify the prevalence of ADHD among children who were born addicted to drugs. If this data
shows a correlation between the two conditions, it will provide the support to intervene early and to
improve outcomes for mothers, infants and families.
Methods: The University of Kentucky Center for Clinical and Transitional Science (CCTS) group extracted
data from Sunrise Clinical Manager and Ambulatory Electronic Health Records to identify the samples
needed for the study. The primary sample criterion was patients being treated at the University of
Kentucky Neonatal Intensive Care Unit for NAS at any time from August 1st, 2008 until August 1st, 2018.
ICD 9 and ICD 10 billing codes were then used to search this sample population for children with a
diagnosis of ADHD, medication prescription for Guanfacine, Adderall, Ritalin (methylphenidate), and
Focalin (dexmethylphenidate), and zip code (first 3 digits). These data points were extracted to see
which children with NAS developed ADHD, and where these patients lived.

ii

NAS and ADHD
Results: 1432 patients were identified from the electronic health records as having NAS during the
requested time range. Of these patients, 22 (1.5%) had a subsequent diagnosis of ADHD, and 31 (2.1%)
had subsequent pharmacologic treatment with one or more of the ADHD medications. Only 157 (10.9%)
of the patients live in Fayette County, and 329 (22.9%) live in a neighboring county. Nine hundred and
forty six (66%) of the patients live further than two counties away from Fayette County.
Conclusion: Current research shows a 30-60% correlation between NAS and subsequent development of
ADHD, which is much higher than the data present in this study. Many patients with NAS that are
treated at the University of Kentucky NICU are transferred from outside hospitals and live far away from
Lexington, in areas where traveling to the University for primary care may not be feasible. If the patient
doesn’t return to a University of Kentucky outpatient clinic then they were not captured in the ADHD
data, regardless if they suffered from the condition or not. Many of the patients with NAS (up to 88.9%
of them) live in Eastern Kentucky and may not be included in the ADHD portion of the data. As a result,
patient education programs on the short-term and long-term effects of NAS, including the risk of ADHD
and other developmental disorders, and early intervention services for children and families may be
more effective in the counties where the patient and families reside.
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NAS and ADHD
Introduction
Neonatal abstinence syndrome (NAS) is the set of signs and symptoms present in a newborn
whose mother was suffering from substance use disorder while pregnant. NAS can occur due to
maternal use of legal, illegal, prescribed, and non-prescribed drugs during pregnancy. Some commonly
abused drugs include heroin, codeine, methamphetamines, methadone, antidepressants,
benzodiazepines, and caffeine. The syndrome is becoming a major health problem in many areas of the
United States, especially in rural and poorer states like Kentucky (Kentucky Department for Public
Health, 2015). According to the CDC, the incidence of NAS quadrupled from 1999-2013, and Kentucky
was one of the most strongly affected states in the nation (Duncan, 2016). Records indicate that the
number of NAS newborns discharged from Kentucky hospitals has increased 23-fold since 2000; going
from 46 in 2001 to 1060 in 2014 (Kentucky Department for Public Health, 2015). In one study quoted by
Kocherlakota (2014), maternal opioid use in the United States increased from 1.2 mothers per 1,000 in
2000 to 5.6 mothers per 1,000 in 2009. In that time, NAS cases nearly tripled, from 1.2 to 3.4 per 1,000
births (Kocherlakota, 2014).
These babies can develop mild to severe withdrawal symptoms in the immediate post-natal
period which can lead to hospitalization in the NICU. Research on the long-term effects of NAS is limited.
However, recent studies have shown that children can develop neurocognitive delays even after
successful detoxification in the NICU, as evidenced by heightened NICU Neurobehavioral Scale, ADHD
Rating Scale, and Bayley Infant Record Behavior scores (Logan, Brown, & Hayes, 2014).
One of the neurocognitive issues that is common in individuals who suffered from NAS as
infants is attention-deficit/hyperactivity disorder (ADHD). ADHD is a pediatric neurodevelopmental
disorder that is marked by inattention, hyperactivity, and impulsivity (National Institute of Mental
Health, 2019). Risk factors for ADHD include genetics; exposure to environmental toxins during
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pregnancy or during childhood; low birth weight; and smoking, alcohol, or drug use during pregnancy
(NIMH, 2019). Signs and symptoms of ADHD can begin as early as age 3, and can persist in to
adolescence and early adulthood. Diagnosis of ADHD involves the identification of signs/symptoms
involved with chronic inattention, hyperactivity, and impulsivity that interferes with school and activities
of daily living. Some of these signs and symptoms include (NIMH, 2019):
-

Inattention: overlooking or missing details; having problems sustaining interest and
attention in play, conversation, and reading; not being able to listen when spoken directly
to; having problems with organization; losing things easily; being easily distracted; and being
forgetful with daily activities.

-

Hyperactivity/Impulsivity: being fidgety while sitting; leaving their seat in situations where
sitting is required; being unable to be quiet in situations that require it; nonstop talking;
having trouble waiting their turn; blurting out answers and finishing other people’s
sentences; and interrupting/intruding on other people’s games and activities.

As NAS rates soar, research is underway to find out how drug exposure affects the brain longterm. According to Kocherlakota (2014), animal experiments are underway to find a connection
between maternal opioid use and fetal brain growth. While this connection has yet to be proven or
disproven, studies are showing that these fetuses have altered maturation of neurons and smaller
neuroanatomic volumes, perhaps demonstrating the link between NAS and smaller head circumference
(Kocherlakota, 2014). Kocherlakota (2014) also discusses the need for follow-up care in pediatric
specialties related to altered CNS function, such as neurology (related to delayed motor development
and microcephaly), ophthalmology (related to nystagmus, strabismus, and other visual defects), and
psychiatry (related to hyperactivity, impulsivity, and ADHD).
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Many researchers have discussed the correlation between NAS and cognitive delay in childhood.
For example, Lall (2008) found that cocaine exposure was linked to higher rates of cerebral palsy, low IQ
scores, increased delinquent behavior, and poor language development. In addition, Klinger et al. (2011)
found that children with NAS have smaller head circumferences at birth, and commonly test lower on
the Denver Developmental Screen Test 2 (DDSTII) at age 6. Also, Logan, Brown, and Hayes (2014) found
that opioid-exposed infants scored lower on the Bayley Scaled of Infant Development (BSID) at ages 18
and 36 months. Researchers haven’t figured out exactly why these correlations occur and what
pathophysiologic changes precede them. However, it is important for healthcare providers to know that
NAS is linked to cognitive issues later in life, and that they should initiate therapy and preventative
measures early and often.
Nygaard, Slinning, Moe, and Walhovd (2016) found that children at ages 4 ½ and 8 ½, who
were treated for NAS were more likely to show ADHD symptoms (per the ADHD Rating Scale) than
children who were not exposed. In Kentucky, teachers are beginning to notice these signs and symptoms
earlier and more often in Kindergarten-aged children. A Director of Advocacy for the Kentucky School
Board Association notes that educators in the state are “seeing the first generation of children enter our
schools in Kentucky, in Kindergarten and first grade that were born with NAS resulting from the current
opioid crisis”. These children have significant developmental delays that directly correlate with NAS
rates (Acquisito and Spears, 2019). This trend is resulting in more children with behavioral issues and
more children needing special education services in the school system (Acquisito and Spears, 2019).
Drug abuse is becoming a major health problem, and as a result NAS rates are rapidly increasing.
In 2014, Kentucky NICUs saw a 7% increase in NAS visits (Duncan, 2016), and it is becoming a major
problem in poorer/rural states where opioid addiction is at an all-time high. Researchers are learning
more about the sequelae of NAS in older children, and pediatric primary care providers have a
responsibility to treat these conditions as early as possible to prevent developmental delays in children
3
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as they age. ADHD is one of the conditions commonly found in children with a history of NAS (RichardsGustafson, 2017), and after synthesizing the evidence, it is clear that there is a correlation between the
two. This correlation can provide the basis for evidence-based education programs aimed at preventing
and treating children and families that have experienced NAS.
Research Barriers
Research on the correlation between NAS and ADHD is limited, in large part because many
factors may contribute to developmental and cognitive delays in childhood. According to Acquisito and
Spears, “certain developmental delays and disabilities are a consequence of the opioid crisis, but we
don’t know which piece” (Acquisito and Spears, 2019, pg. 4). Other socioeconomic factors that may
contribute to developmental and cognitive delays include parents’ financial instability, unsafe housing,
abuse, incarceration, and being in the care of foster or adoptive parents.
The University of Kentucky Neonatal Intensive Care Unit (NICU) is one of the only NICU’s in
Kentucky that treats NAS. In general, any baby suffering from NAS who is delivered at a hospital in
Eastern/Appalachia Kentucky will be transferred to the University of Kentucky hospital for a higher level
of care. The University of Kentucky hospital provides higher acuity care than most Eastern Kentucky
hospitals, but this transfer may create socioeconomic strains on the family, which can be especially
difficult given the conditions that many of the people in that region face already. The number of babies
born with NAS in Eastern/Appalachian Kentucky as high as 65 cases per 1,000 live births; nearly 3 times
higher than the Kentucky rate of 22 cases per 1,000 live births (Acquisito & Spears, 2019). This places a
significant strain on the parents of children with NAS in this area, as well as on the University of
Kentucky NICU staff. Many of these families are inconvenienced by their child receiving care in a hospital
that may be hours away from home. These families may not return to the hospital for follow-up care,
and that may exacerbate efforts for follow-up care of these children. Research suggests that patients
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will not travel further than 20-30 miles for routine primary care (Yen, 2013), so it can be assumed that
many of the patients treated for NAS at UK Healthcare will be lost to outside hospitals and clinics for
follow-up care.

Purpose
The purpose of this project was to determine if there was a correlation between NAS and ADHD
at a large university hospital. The literature makes it clear that children with NAS often suffer from longterm cognitive and developmental complications. Unfortunately, the same research shows that the
causes and correlations are not easily identifiable. This DNP project was a retrospective chart review
aimed at identifying a correlation between NAS and ADHD. Electronic health records at a large university
hospital were searched for key words and ICD codes to identify children who were treated at the
hospital for NAS, and of those children, which ones went on to have a diagnosis of ADHD. The goal of
this search is to provide tangible evidence of a correlation between NAS and ADHD. These data can be
the foundation for evidence-based education programs aimed at helping children and families with NAS.

Methods
The data were extracted from the electronic health record with the help of the Center for
Clinical and Transitional Science (CCTS) group. De-identified data that met the inclusion and exclusion
criteria were extracted. ICD 9 and ICD 10 codes were used as the basis for the inclusion criteria search.
The following codes were used in the data search:
-

ICD-9 diagnosis codes:
o

779.5 – drug withdrawal syndrome in the newborn
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-

o

314.01 – attention deficit disorder without mention of hyperactivity

o

314.01 – attention deficit disorder with hyperactivity

ICD-10 diagnosis codes:
o

P96.1 – neonatal withdrawal symptoms from maternal use of drugs of addiction

o

F90.0 – attention-deficit hyperactivity disorder, predominantly inattentive type

o

F90.2 – attention-deficit hyperactivity disorder, combined type

o

F90.9 – attention-deficit hyperactivity disorder, unspecified type

The primary inclusion criterion, which provided the total sample population of the study, was a
diagnosis of NAS within the date range of August 1st 2008 to August 1st 2018. From this population, the
following secondary inclusion criteria were extracted: diagnosis of ADHD, medication prescription for
Guanfacine, Adderall, Ritalin (methylphenidate), Focalin (dexmethylphenidate), and zip code.
Institutional Review Board (IRB) approval for this project was obtained on October 8th, 2019.
Setting and Sample
This retrospective chart review was conducted by the University of Kentucky Center for Clinical
and Translation Science (CCTS) and was exported from Sunrise Clinical Manager and Ambulatory
Electronic Health Record, both of which are electronic health database systems utilized by the
University. It involved a search for every child that was treated for Neonatal Abstinence Syndrome (NAS)
in the University of Kentucky NICU for a 10-year period beginning August 1st, 2008 and ending August 1st,
2018. Acquisito and Spears (2019) estimate that the opioid crisis in Kentucky began around 2009, which
is why this 10-year period was used for the chart review. In total, 1432 NAS babies were isolated from
the CCTS database search. This was the sample that was used to search for the necessary inclusion
criteria.
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Theoretical Framework
NAS can be considered a tertiary result of maternal drug use: the mother develops an addiction
to a drug, the mother uses the drug before and/or during pregnancy, and as a result the child is born
addicted to the drug. If proper primary and secondary preventions are implemented, NAS can be
prevented (Hamdan, 2017). Drug cessation, proper prenatal care, and proper treatment for pregnant
women with substance use disorders can eliminate or quell the signs and symptoms of NAS. Addiction is
a multifaceted condition, and Neuman’s Systems Model can provide a framework for treating this
problem. Neuman’s model focuses on a person’s reaction to stress, and uses a multidimensional and
holistic approach in treating it (Fulbrook, 1991). The major concepts of the model include the person,
the environment, health, and nursing, and Neuman emphasizes that primary, secondary, and tertiary
care may all be required in the treatment of a given condition (Fulbrook, 1991). Care of the mother who
has been addicted to opioids, care of the baby with NAS, and prevention of complications later in life
involve all of these factors.

Results
Of the 1432 children in the sample population, 832 (58.1%) infants were male and 600 (41.9%)
were female. Many different races were represented, but the majority of them were Caucasian (1331,
92.9%). The most surprising statistic to come from the data search was that only 22 (1.5%) children had a
diagnosis of ADHD. In addition, 31 (2.1%) children were prescribed an ADHD medication. These were
children seen at UK Health Care clinics who did not have an ADHD diagnosis through UK Health Care, but
were prescribed an ADHD medication there. These children were likely diagnosed with ADHD at an outside
facility but were seen at UK Health Care for an unrelated issue. The preceding statistics show that at most,
53 (3.6%) children in the NAS population sample developed an ADHD diagnosis. This data is clearly
7
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inconsistent with current evidence-based research. At this point, zip codes were added to the inclusion
criteria to examine where these patients with NAS live. The University of Kentucky NICU is one of the
primary NAS treatment centers in the state, and many families may have to travel a long way from home
while their babies are being treated. Many of these children may not ever return to the University of
Kentucky for primary care treatment, which is why county of residence played a role in the interpretation
of the data. Interestingly, the zip code data shows that most of the children in the population sample live
in areas outside of Lexington:
- 157 (10.9%) children were from Lexington
- 329 (22.9%) children resided in a county that is within 2 counties of Fayette County KY
- 42 (2.9%) children live in counties west of Fayette County KY
- 295 (20.6%) children live in counties that are north or south of Fayette County KY and its
surrounding counties
- Between 514 and 823 (36-58.8%) children live in counties east of Fayette County.

Discussion
More than 61.9% of the children in this study live further than one county away from Fayette
County. This was a large portion of the sample size. Current evidence-based research estimates the rate
of ADHD among babies with NAS to be anywhere from 30-40%, much higher than the 3.6% estimated in
this study. Children are being discharged from the University of Kentucky Hospital to homes that are
several counties away, and they never return to this hospital or primary care clinics within the university
healthcare system, and were not be captured in this study.
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Implications for Practice
As the opioid crisis gets worse, the number of NAS cases in the United States increases. NAS is
not a new diagnosis; however, studies on the long-term effects of NAS are limited. The goal of this
project was to see if a link between NAS and ADHD exists in hopes of expanding the literature. These
data could be beneficial to providers in many areas, including general pediatrics, behavioral and
developmental pediatrics, and OB-GYN. A few ways that this research could help providers within the
university setting include:
-

General Pediatrics: Identify children who may be at risk for ADHD due to a verified history of
NAS. Pediatric providers could begin teaching the parent about the early signs and
symptoms of ADHD in kids who may be at risk. Programs, such as the Incredible Years
Parenting Program, which is an evidence-based parenting program, could be beneficial in
helping families and be delivered in primary care offices where these families reside.

-

OB-GYN: If the OB-GYN knows that the mother has a history of drug use, and if they suspect
that they will deliver a baby with NAS, the OB-GYN could begin patient education on the
signs/symptoms of withdrawal and other helpful evidence-based interventions.

-

Family practitioners and drug counselors: This project highlights the importance of providing
evidence-based treatments to support mothers to stop using drugs. A campaign aimed at
women during childbearing years may help to decrease drug use and prevent NAS.

Current evidence-based research is showing improved NAS outcomes from effective antidrug
education during pregnancy and before conception. Education aimed at getting mothers to stop taking
drugs during pregnancy would have a direct and positive impact on babies. NAS can be reduced or even
eliminated with effective primary care either early in pregnancy or pre-conception (Ko et al., 2017).
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Nearly 86% of pregnancies involving mothers with opioid addiction are unintentional, so NAS education
must occur quickly and as soon as the mother begins seeking prenatal care (Ko et al., 2017).
Data from this project shows that a large percentage of children with NAS live in eastern
Kentucky. Therefore, providing services and interventions in this area may improve outcomes for these
children. Infants with NAS who are raised by their biological families tend to score lower on the Bayley
Scales of Infant Developmental-Mental Developmental Index (Shearer et al., 2018). In addition, infants
with NAS who live in homes with lower socioeconomic status were much more likely to score lower on
multiple developmental tests than those in homes with average to high socioeconomic status (Shearer
et al., 2018). Intellectual outcomes were similar to developmental outcomes: infants with NAS were
much more likely to suffer from intellectual disabilities at one year, 18 months, and three years, and 7th
graders with NAS tend to score less than or at a 5th grade level on standardized tests (Shearer et al.,
2018). Babies with NAS are more likely to be born with smaller head circumferences and have abnormal
MRI scans, as evidenced by decreased volumes of basal ganglia and cerebellar white matter, at ages 1014 (Shearer et al., 2018). Babies with NAS may have cognitive and developmental delays. These issues
are compounded when they occur in rural, poor areas like Eastern and Appalachian Kentucky.
Eastern Kentucky is one of the poorest economic regions in the country. Of all the counties that
lie east of I-75, 36 of them are considered ‘distressed’ by a survey conducted by the Appalachian
Regional Commission of the U.S. Census Bureau (see Appendix C). The area is among the poorest and
most rural in the nation, and median household income is well below the national average in nearly
every county. These socioeconomic factors, when combined with higher rates of opioid use, compound
the effects of NAS on children growing up in these areas. As many as 25% of children with opioid
exposure may not receive necessary healthcare within the first 2 years of life (Shearer et al., 2018).
Further, children with NAS who grow up with mothers who suffer from substance use disorder are much
more likely to develop mental health disorders as adults, and this correlation can predict future drug use
10
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by up to 50% (Shearer et al., 2018). Considering these facts, as well as the facts present throughout this
study, Eastern Kentucky is an area that may benefit from NAS education. Through the University of
Kentucky’s Area Health Education Centers (AHEC), delegates from the university work to train, support,
and recruit effective healthcare providers in all areas of the state. Nearly 60% of babies with NAS seen at
the University of Kentucky NICU reside in counties within the Northeast and Southeast AHEC’s (see
Appendix A). Healthcare professionals in these areas should be trained about NAS, its signs and
symptoms, and how to properly treat and wean mothers with substance use disorder who are pregnant
or thinking about becoming pregnant. This education should include the importance of weaning off
drugs as soon as they know they are pregnant, the use of Subutex programs, and the short and longterm consequences of NAS (if they choose to continue using drugs).
Limitations
The major limitation of this study is that children who were not seen for follow-up ADHD
treatment were not included in the results. If a child was treated for NAS at UK Healthcare, but never
returned to UK for follow-up care or received their ADHD diagnosis at an outside clinic, the ICD 9 and
ICD 10 codes for their diagnoses were not captured in the follow-up data. If it had been somehow
possible to track these children at their respective healthcare facilities, ADHD rates for this study may
have been more consistent with nation-wide studies that show a much higher incidence.

Conclusion
Neonatal abstinence syndrome isn’t a new health problem, but it is becoming more common
due to the worsening opioid crisis in the United States. The long-term effects of the condition are not
well studied, but data suggests that children are developing chronic developmental, behavioral, and
cognitive problems. These conditions have origins that may be hard to pinpoint, because there may be
11
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many contributing factors: socioeconomic status, wealth, living conditions, marital status, and access to
quality healthcare are just a few factors that may initiate or exacerbate cognitive and developmental
changes to the brain. Data, as well as first-hand accounts from teachers, parents, and healthcare
providers in high risk areas are seeing an increase in children with developmental delays, behavioral
problems, and the need for special education services. While it isn’t possible to label NAS as the only or
major cause, it is certainly possible to assume that it is a major causative factor.
NAS is the result of drug use during pregnancy, and it can be completely avoided in parents who
do not use these substances, or in those who cease using these substances once they become pregnant.
The major goal of patient education is to enlighten people and promote change, and NAS is a condition
that can be prevented with proper prenatal and pre-pregnancy patient education. This education should
focus on the short and long-term consequences of the condition, ranging from the gastrointestinal and
neurologic withdrawal symptoms present at birth to the potential developmental and cognitive
deficiencies noted in school aged and adolescent children. Eliminating NAS would have a profound
impact on patient outcomes, especially in poor and disadvantaged areas, as well as promote cost
savings in a variety of healthcare areas. Kentucky is one of the poorest and most rural states in the
country, and likewise opioid use and NAS rates are very high in many areas of the state. As a leader of
healthcare in Kentucky, and as one of the only NAS treatment centers in the state, the University of
Kentucky, through outreach programs, can impact the community where NAS rates are prevalent and
improve outcomes for children and families living within the state.
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Map of Kentucky Area Health Education Centers
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Appendix B
Distribution of University of Kentucky Babies with NAS in Kentucky Zip Codes

< 10 Children = GRAY
11-20 Children = GREEN
21-40 Children = YELLOW
41-60 Children = ORANGE
61-100 Children = RED
> 100 Children = BLACK
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Appalachian County Economic Levels

20

NAS and ADHD
Appendix D
Data Tables from CCTS Chart Extract

GENDER
900
800
700
600
500
400
300
200
100
0
FEMALE

GENDER
FEMALE
MALE

MALE

COUNT
600
832

21

NAS and ADHD

RACE
1400
1200
1000
800
600
400
200
0
American
Indian

RACE
AMERICAN INDIAN
ASIAN
BI-RACIAL
AFRICAN AMERICAN
REFUSE
SPANISH AMRICAN
UNREPORT
WHITE

Asian

Bi-Racial

African
American

COUNT
2
1
2
46
1
1
22
1331

22

Refused

Spanish
American

Unreported

White

NAS and ADHD

ADHD
1600
1400
1200
1000
800
600
400
200
0
N

ADHD
N
Y

Y

COUNT
1410
22

23

NAS and ADHD

MEDICATION PRESCRIPTION
1600
1400
1200
1000
800
600
400
200
0
N

MEDICATION PRESCRIPTION
N
Y

Y

COUNT
1401
31

24

NAS and ADHD

ZIP CODE
350
300
250
200
150
100
50
0
400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 420 421 425 426 427

ZIP CODE
400 (Shelby, Nelson, Trimble, Oldham, Jefferson, Marion, Washington, Henry, Spencer)
401 (Bullitt, Breckinridge, Hardin, Meade, Nelson, Grayson, Jefferson)
402 (Jefferson)
403 (Mercer, Nicholas, Powell, Rowan, Menifee, Scott, Marion, Estill, Bourbon, Owen, Bath,
Montgomery, Jessamine, Anderson, Woodford, Clark)
404 (Madison, Jackson, Rockcastle, Garrard, Estill, Lincoln, Boyle)
405 (Fayette)
406 (Franklin)
407 (Laurel, Whitley, Knox)
408 (Harlan, Letcher, Leslie, Bell)
409 (Knox, Clay, Bell, Whitley, Harlan)
410 (Harrison, Bracken, Boone, Owen, Campbell, Gallatin, Fleming, Mason, Robertson,
Grant, Carroll, Kenton, Fleming, Pendleton)
411 (Carter, Greenup, Boyd, Elliott, Lewis, Lawrence)
412 (Johnson, Martin, Floyd, Lawrence)
413 (Morgan, Wolfe, Lee, Owsley, Breathitt, Perry, Lee)
414 (Morgan, Magoffin)
415 (Pike, Letcher)
416 (Floyd, Magoffin, Knott)
417 (Perry, Leslie, Knott)
418 (Perry, Letcher, Knott)
420 (McCracken, Carlisle, Marshall, Hickman, Crittenden, Lyon, Fulton, Calloway, Graves,
Livingston, Ballard)
421 (Warren, Allen, Barren, Simpson, Edmonson, Metcalfe, Monroe)
425 (Casey, Pulaski)
426 (Clinton, Russell, McCreary, Wayne)
427 (Hardin, LaRue, Hart, Adair, Grayson, Cumberland, Taylor, Green)

25

COUNT
13
2
2
329
156
157
13
116
13
84
46
29
16
61
15
21
23
57
33
2
2
48
45
8

NAS and ADHD
Appendix E

APA Citation

Purpose
Statement

Study Design

Sample

Key Findings

Sandtorv, L.B., Fevang, S.K.E.,
Nilsen, S.A., Boe, T., Gjestad, R.,
Haugland, S., and Elgen. I.B.
(2018). Symptoms Associated
With Attention
Deficit/Hyperactivity Disorder
and Autism Spectrum Disorders
in School-Aged Children
Prenatally Exposed to
Substances

To evaluate
the mental
health
symptoms
associated
with prenatal
substance
abuse

Cross-sectional

57 children, ages 6-14, from
a large hospital in Norway,
who were exposed to illicit
drugs in-utero

37% of the children
presented with high
risk symptoms of
ADHD based on the
SNAP-IV

Nygaard, E., Slinning, K., Moe,
V., and Walhovd, K.B. (2016).
Behavior and Attention
Problems in Eight-Year-Old
Children with Prenatal Opiate
and Poly-Substance Exposure: A
Longitudinal Study

To investigate
whether
behavior and
attention
problems are
more
prominent in
children who
were exposed
to drugs
prenatally.

Longitudinal

136 infants (78 who were
exposed in utero and 58
who were not exposed)
were recruited from a large
hospital in Norway. Their
development was followed
until age 8 ½. The ADHD
rating scale was used at age
4 ½ and at age 8 ½.

25% of the at-risk
children had scores
that were indicative
of ADHD, and an
additional 17% had
scores suggesting
ADHD-related
problems.

Simes, E., Oltedal, L., Bartsch,
H., Eide, G.E., Elgin, I.B., and
Aukland, S.M. (2017). Brain
morphology in school-aged
children with prenatal opioid
exposure: A structural MRI
study. Early Human
Development. 106: 33-39.

To investigate
the association
between
prenatal opioid
exposure and
brain
morphology in
school-aged
children.

A cross-sectional
study of prenatally
opioid-exposed
children

A sample of 16 children,
aged 10-14 with prenatal
exposure to opioids

Volumes of the basal
ganglia, thalamus,
and white matter
were reduced in the
opioid-exposed
group.
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Study Design
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Key Findings

Klinger, G.,
Frankenthal, D.,
Merlob, P., Diamond,
G., Sirota, L., LevinsonCastiel, R., Linder, N.,
Stahl, B., and Inbar, D.
(2011). Long-term
outcome following
selective serotonin
reuptake inhibitor
induced neonatal
abstinence syndrome

To assess the
neurodevelopment
outcomes of children
exposed to SSRI’s in
utero that developed
a neonatal
abstinence syndrome

Prospective
cohort design

30 children with
NAS and 52
children without
NAS were recruited
from a large Israeli
hospital.

27% of the children with NAS had
lingual abnormalities and 47% of
the children with NAS had social
abnormalities (based on the Denver
Developmental test)

Yeoh, S.L., Eastwood,
J., and Wright, I.M.
(2019). Cognitive and
motor outcomes of
children with prenatal
opioid exposure.

Key Question: is
prenatal opioid
exposure associated
with differences in
childhood cognitive
and motor
development?

Systemic
review and
meta-analysis
of cohort
studies
involving
children with
prenatal
opioid
exposure

Meta-analysis of 26
studies, which
included 1455
children exposed to
prenatal opioids

Up to 6.3% of children with prenatal
opioid exposure will have an IQ
score 2 standard deviations below
normal, compared to 2.3% of
normal children. Thus, these
children are 3 times more likely to
have a severe intellectual disability
based on DSM-5 criteria

Nygaard, E., Slinning,
K., Moe, V., and
Walhovd, B. (2015).
Cognitive function of
youths born to
mothers with opioid
and poly-substance
abuse problems
during pregnancy

To evaluate the
outcomes of children
exposed to drugs
prenatally

Longitudinal
study

45 children born to
mothers who were
poly-substance
users and 48
children who were
born without
prenatal exposure.
Participants were
administered 10
neuropsychologic
tests between ages
17-21

36% of the children in the at risk
group were diagnosed with ADHD
at some point in childhood.

27

13% of people in the risk group
developed substance abuse or
addictions in their teens

